Cargando…
Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic
In the coming decades, a massive shift in the aging segment of the population will have major social and economic consequences around the world. One way to offset this increase is to expedite the development of geroprotectors, substances that slow aging, repair age‐associated damage and extend healt...
Autores principales: | Moskalev, Alexey, Chernyagina, Elizaveta, Tsvetkov, Vasily, Fedintsev, Alexander, Shaposhnikov, Mikhail, Krut'ko, Vyacheslav, Zhavoronkov, Alex, Kennedy, Brian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854916/ https://www.ncbi.nlm.nih.gov/pubmed/26970234 http://dx.doi.org/10.1111/acel.12463 |
Ejemplares similares
-
Geroprotectors: A Unified Concept and Screening Approaches
por: Moskalev, Alexey, et al.
Publicado: (2017) -
Genome-Protecting Compounds as Potential Geroprotectors
por: Proshkina, Ekaterina, et al.
Publicado: (2020) -
Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease
por: Moskalev, Alexey, et al.
Publicado: (2015) -
Terpenoids as Potential Geroprotectors
por: Proshkina, Ekaterina, et al.
Publicado: (2020) -
In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state
por: Aliper, Alexander, et al.
Publicado: (2016)